Skip to main content
. Author manuscript; available in PMC: 2009 May 11.
Published in final edited form as: Stroke. 2008 Dec 8;40(3 Suppl):S16–S19. doi: 10.1161/STROKEAHA.108.533174

Table 1.

Progression of CAA

Elevated
soluble Aβ
Early CAA Moderate CAA Advanced CAA Dyshoric
vessels
Vascular
Pathology
None None Altered VSMC
architecture
Amyloid
replacement of
VSMCs
Fibrinoid
necrosis,
microaneurysms
Cell death None None VSMCs
(early loss)
VSMCs
(severe loss)
VSMCs, CECs,
pericytes
Vascular
Function
Impaired
reactivity
(moderate)
Impaired
reactivity
(severe)
Absent
reactivity
Absent
reactivity
Absent
reactivity
Brain
Pathology
None White matter disease and cortical infarcts Frank
hemorrhage
Clinical ? Cognitive dysfunction? Major M&M

VSMCs, vascular smooth muscle cells

CECs, cerebral endothelial cells